CINRX PHARMA, LLC reported 1 transaction at CINCOR PHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 1/13/2022ACC: 0001209191-22-003200
-2.93M
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
1.22M acquired · 4.16M disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+1.22M
Price / share
—
Trade value
—
% of position
50.8%
1/11/2022
2.41M→3.63M
Total
Net shares
+1.22M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/11/2022 | C · Conversion | +1.22M | — | — | 50.8% | 2.41M | 3.63M |
| Total | +1.22M | $0.00 | ||||||
Derivative Transactions2
Series A Preferred Stock
Direct
Converts to
Common Stock
630.25K shares
Shares
−2.14M
Strike price
Held after
0.00
Exercisable
—
1/11/2022
Series B Preferred Stock
Direct
Converts to
Common Stock
592.28K shares
Shares
−2.01M
Strike price
Held after
0.00
Exercisable
—
1/11/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Preferred Stock Direct | Common Stock630.25K shares | 1/11/2022 | C · Conversion | −2.14M | — | 0.00 | |
| Series B Preferred Stock Direct | Common Stock592.28K shares | 1/11/2022 | C · Conversion | −2.01M | — | 0.00 |